Asbestosis is a chronic fibrotic interstitial lung disease caused by inhalation of asbestos fibres. It is classified as a pneumoconiosis and typically develops after substantial occupational or environmental exposure over a prolonged period, often with a latency of many years or decades. Asbestos refers to several naturally occurring fibrous silicate minerals whose heat resistance, tensile strength and insulating properties led to extensive historical use in construction, shipbuilding, insulation, manufacturing and other industries. Inhaled fibres can reach the distal respiratory tract and become embedded in lung tissue, where they provoke persistent inflammatory and fibrotic responses. Asbestosis is therefore an exposure-related disease rather than an acute poisoning and can continue to manifest long after the original exposure occurred.
The pathogenesis of Asbestosis involves inhaled asbestos fibres interacting with alveolar macrophages and other pulmonary cells. Long, durable fibres can be difficult for macrophages to clear effectively, producing a process known as frustrated phagocytosis in which inflammatory and fibrogenic signalling persists. Reactive oxygen and nitrogen species, cytokines and growth factors contribute to tissue injury and fibroblast activation, ultimately causing diffuse interstitial fibrosis. Fibrotic tissue reduces normal lung compliance and interferes with oxygen transfer across the alveolar-capillary membrane. The severity of disease depends on cumulative exposure, fibre characteristics and individual susceptibility. Cigarette smoking does not cause asbestosis itself but can compound respiratory impairment and is especially important because asbestos exposure also increases lung cancer risk.
Clinical disease often develops gradually. Early Asbestosis may produce no symptoms or only mild exertional breathlessness, while more advanced disease can cause persistent dry cough, reduced exercise capacity and progressive respiratory limitation. On examination, fine inspiratory crackles may be present, although physical findings vary. Severe fibrosis can impair gas exchange and contribute to respiratory failure or pulmonary hypertension. The presence of pleural abnormalities such as pleural plaques can provide evidence of previous asbestos exposure but should not be confused with asbestosis because plaques are localised pleural changes and do not themselves represent diffuse interstitial pulmonary fibrosis.
Diagnosis requires a credible history of asbestos exposure combined with compatible clinical and radiological findings. Chest radiography can show characteristic diffuse interstitial changes, while high-resolution computed tomography is more sensitive for detecting and characterising fibrosis and pleural abnormalities. Pulmonary function testing can demonstrate restrictive physiology and reduced gas-transfer capacity, although early disease may produce relatively subtle abnormalities. A detailed occupational history is essential because asbestos exposure may have occurred decades earlier and may involve several employers or industries. Differential diagnoses include other interstitial lung diseases and pneumoconioses, so radiology alone cannot reliably establish occupational causation without considering exposure history and the complete clinical picture.
Asbestosis has important relationships with other asbestos-related diseases. Asbestos exposure can cause pleural plaques, diffuse pleural thickening, certain pleural malignancies and increased risk of lung cancer, while asbestosis specifically refers to diffuse pulmonary interstitial fibrosis. Mesothelioma is therefore not another name for asbestosis; it is a malignant tumour associated strongly with asbestos exposure but biologically distinct from fibrotic lung disease. The latency between exposure and disease can be exceptionally long, making historical occupational records valuable. The absence of current exposure does not negate the relevance of past exposure because disease may become clinically apparent long after exposure ceased.
There is no treatment that reliably removes asbestos fibres from the lungs or reverses established asbestotic fibrosis. Management therefore focuses on preventing further exposure, monitoring respiratory function, treating complications and addressing coexisting respiratory disease. Smoking cessation is particularly important for exposed workers because smoking and asbestos exposure together substantially increase lung cancer risk. Vaccination and appropriate management of respiratory infections can be relevant to people with chronic lung impairment. Oxygen therapy may be required in advanced disease with significant hypoxaemia, and specialist respiratory assessment may be necessary when disease becomes severe.
Prevention is based on avoiding inhalation of airborne asbestos fibres. Because asbestos-containing materials can remain in older buildings and industrial infrastructure, risk can arise during maintenance, refurbishment, demolition or accidental disturbance rather than only during historical manufacturing. Safe work requires identification and assessment of asbestos-containing materials, controlled work practices, appropriate containment and specialist procedures where required. Personal respiratory protection is an additional measure but should not replace source control and proper asbestos management. Disturbing asbestos-containing material can release fibres that are not visible individually, so visual inspection alone cannot establish whether exposure is safe.
Asbestosis is a particularly important example of the long-term consequences of occupational exposure because disease can have a prolonged latency and irreversible pathological component. It is not contagious, and ordinary contact with a person who has asbestosis does not transmit asbestos fibres. Family members can historically have experienced exposure through contaminated clothing or occupational take-home dust, however, which illustrates why exposure control extends beyond the worker.
Another misconception is that any asbestos exposure inevitably causes asbestosis; disease risk depends on exposure characteristics and individual circumstances, although asbestos should be treated as a serious occupational hazard. The distinction between asbestosis and other asbestos-related diseases is essential for accurate medical, occupational and legal assessment.
